ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 128 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | +50.0% | 20,000 | -0.0% | 0.00% | +100.0% |
| Q2 2022 | $20,000 | -31.0% | 20,001 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $29,000 | -72.1% | 20,081 | +0.4% | 0.00% | -75.0% |
| Q4 2021 | $104,000 | -96.9% | 20,001 | -96.6% | 0.00% | -96.9% |
| Q3 2021 | $3,404,000 | -71.9% | 583,792 | -61.2% | 0.13% | -72.8% |
| Q2 2021 | $12,135,000 | -8.4% | 1,505,538 | -5.5% | 0.47% | -15.2% |
| Q1 2021 | $13,255,000 | +8.7% | 1,593,126 | -0.9% | 0.56% | +2.6% |
| Q4 2020 | $12,190,000 | -41.9% | 1,608,235 | -18.2% | 0.54% | -49.4% |
| Q3 2020 | $20,967,000 | +83.1% | 1,966,891 | +160.3% | 1.08% | +62.3% |
| Q2 2020 | $11,453,000 | +53.2% | 755,483 | -15.8% | 0.66% | +10.1% |
| Q1 2020 | $7,478,000 | -66.3% | 897,759 | -31.7% | 0.60% | -55.5% |
| Q4 2019 | $22,208,000 | +35.7% | 1,314,093 | +49.1% | 1.36% | +23.6% |
| Q3 2019 | $16,367,000 | +30.9% | 881,390 | +61.3% | 1.10% | +37.0% |
| Q2 2019 | $12,499,000 | +20.4% | 546,279 | +10.6% | 0.80% | +13.3% |
| Q1 2019 | $10,380,000 | +112.8% | 493,819 | +16.4% | 0.71% | +77.4% |
| Q4 2018 | $4,878,000 | -66.3% | 424,190 | -32.7% | 0.40% | -60.2% |
| Q3 2018 | $14,460,000 | +20.5% | 630,053 | +17.1% | 1.00% | +3.3% |
| Q2 2018 | $12,002,000 | +82.0% | 538,191 | +86.5% | 0.97% | +10.0% |
| Q1 2018 | $6,593,000 | – | 288,536 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 225,239 | $1,295,123 | 1.10% |
| CHARTIST INC /CA/ | 67,073 | $385,667 | 0.23% |